New York, NY -- (SBWIRE) -- 01/02/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Hudson City Bancorp, Inc (NASDAQ:HCBK), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Coronado Biosciences Inc (NASDAQ:CNDO), China New Borun Corp (NYSE:BORN)
Hudson City Bancorp, Inc (NASDAQ:HCBK) the stock opened the session at $9.43 but then moved to $9.43. At that price, the stock showed a positive performance of 0.43%. Hudson City Bancorp, Inc. (Hudson City Bancorp) serves as the holding company of its subsidiary, Hudson City Savings Bank (the Bank). The Bank is a federal stock savings bank. The Company is a community- and consumer-oriented retail savings bank offering traditional deposit products, residential real estate mortgage loans and consumer loans. In addition,
Will HCBK Continue To Move Higher? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) opened the session at $3.29 and closed the session at $3.36. The stock showed a positive performance of 2.13% in previous trading session. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream,
For How Long AVNR will fight for Profitability? Read This Trend Analysis report
Coronado Biosciences Inc (NASDAQ:CNDO) opened the session at $2.65 and closed the session at $2.63. The stock showed a positive performance of 0.77% in previous trading session. Coronado Biosciences, Inc. is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company’s two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn’s disease (Crohn’s),
Why Should Investors Buy CNDO After The Recent Gain? Just Go Here and Find Out
China New Borun Corp (NYSE:BORN) the stock decreased -10.71% and finished the session at $2.50. Traded with volume of 1.84 million shares in the prior session and the average volume of the stock remained 529,815.00 shares. The beta of the stock remained 2.69. China New Borun Corporation (New Borun) is a producer and distributor of corn-based edible alcohol in the People's Republic of China based on tons of edible alcohol produced. The Company’s edible alcohol products are primarily sold as an ingredient to producers of baijiu, who further blend the Company’s products into finished products sold under various brand names throughout China. Baijiu is a grain-based alcoholic beverage made from corn,
Will BORN Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)